Skip to Main Content

Paper Details

Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19.
iScience
3
2022
Author NameAffiliation
Laura BergamaschiUniversity of Cambridge, Addenbrookes Hospital
Laura BergamaschiCambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge
Patrick F ChinneryCambridge University Hospitals NHS Foundation
Patrick F ChinnerySchool of Clinical Medicine, University of Cambridge
Patrick F ChinneryMedical Research Council Mitochondrial Biology Unit, University of Cambridge
Kathleen StirrupsCambridge University Hospitals NHS Foundation
Kathleen StirrupsSchool of Clinical Medicine, University of Cambridge
Kathleen StirrupsCambridge University Hospitals NHS Foundation
Kathleen StirrupsSchool of Clinical Medicine, University of Cambridge
David K MenonSchool of Clinical Medicine, University of Cambridge
Willem H OuwehandWellcome and MRC Cambridge Stem Cell Institute, University of Cambridge
Willem H Ouwehand
Willem H OuwehandCambridge University Hospitals NHS Foundation
Willem H OuwehandWellcome and MRC Cambridge Stem Cell Institute, University of Cambridge
Willem H OuwehandCambridge University Hospitals NHS Foundation
Willem H Ouwehand
Berthold GöttgensWellcome and MRC Cambridge Stem Cell Institute, University of Cambridge
John C MarioniWellcome Sanger Institute
John C Marioni
John C MarioniCancer Research UK -Cambridge Institute
John C MarioniWellcome Sanger Institute
John C MarioniCancer Research UK -Cambridge Institute
John C Marioni
John R BradleyUniversity of Cambridge, Addenbrookes Hospital
John R BradleyCambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital
John R BradleyCambridge University Hospitals NHS Foundation
  • 1 - 26

Datasets